The molecular connections between insulin action, diabetes, and Alzheimer’s disease, and potential therapeutic interventions focuses on the regulation of glycogen synthase kinase-3 (GSK-3) and impacts neuronal function [28]. The gene discussed is INS; the disease is Alzheimer disease.